The owners of the Nemera medical company are considering the possibility of selling a controlling stake in the company. This is reported by foreign media.
Astorg Partners and Montagu Private Equity are negotiating with consultants regarding the potential sale of Nemera assets, the total value of which is estimated at 3 billion euros ($3.5 billion).
Nemera intends to expand production, taking into account the growing demand for devices for the delivery of popular weight loss drugs based on glucagon-like peptide-1 and insulin therapy (Novo Nordisk A/S’ Wegovy and Eli Lilly & Co.’s Zepbound).
Nemera is a French manufacturer of devices for the treatment of obesity and other diseases (auto-injectors, syringe pens, inhalers, eye droppers and pumps). Production sites are located in the USA, France, Germany, Poland and Brazil. The headquarters is located in La Verpillière in France with a staff of 2 thousand employees.
Montagu Private Equity is a European private investment company in the field of the middle market segment. The headquarters is located in London (UK) with offices in Frankfurt, Paris, Luxembourg and Warsaw. The company manages assets worth 14 billion euros.
Astorg Partners is a European private equity firm with headquarters in Luxembourg and offices in Paris, London, New York, Frankfurt and Milan.
Read our Telegram channel "Mergers and acquisitions. AK&M».
Our channel at MAX is "Mergers and Acquisitions. AK&M».
